| Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer | Zeliha Ertürk MD,Esra Büber MD,Haluk Özen MD,Ömür Çelikbıçak MD,Bekir Salih MD,N Leyla Açan MD | 70–76 |
| The Efficiency of Docetaxel Chemotherapy on Castration Resistant Prostate Cancer: Singe Center Experience | EVREN SÜER,Nurullah HAMİDİ,MEHMET İLKER GÖKCE,SÜMER BALTACI | 77–80 |
| The Effect of Sex and Age Differences on Pathology Results in Primary Bladder Cancer Patients | Hakan Türk MD,Sıtkı Ün MD,Batuhan Ergani MD | 81–85 |
| Do Length and Tumor Grades of Positive Surgical Margin Have an Impact on Biochemical Recurrence After Prostatectomy? | Murat Yavuz KOPARAL,Cenk ACAR,BETÜL ÖĞÜT,Eda TOKAT,Fatih BIÇAKLIOĞLU,İPEK IŞIK GÖNÜL,ALİ FURKAN BATUR,Tevfik Sinan SÖZEN | 86–91 |
| Relationship Between Human Papilloma Virus and Bladder Cancer | Osman İNCİ,EBRU TAŞTEKİN,Hakan AKDERE | 92–94 |
| What are the New Developments in Urinary, Serum and Tissue Biomarkers in Prostate Cancer? | HAYRETTİN ŞAHİN,MEHMET ÇETİNKAYA,HASAN DELİKTAŞ | 95–100 |
| Germ Hücreli Neoplazinin Nadir Bir Prezentasyonu: Persistan Müllerian Kanal Sendromu | Alp Tuna BEKSAÇ,MUHAMMET İRFAN DÖNMEZ,Çisel AYDIN,Dilek ERTOY BAYDAR,MUSTAFA SERTAÇ YAZICI,ALİ ERGEN,BÜLENT AKDOĞAN | 101–104 |
| Primary Adrenal Lymphoma: A Case Report | İLKE ONUR KAZAZ,Ayhan ARSLAN,NERGİZ ERKUT,ÖMER KUTLU | 105–107 |